Clinical Trial Update: Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the functionality of Duragesic fentanyl transdermal system in chronic low back pain; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Duragesic (fentanyl transdermal system)

Snippet

Sponsor: PriCara, Unit of Ortho-McNeil, Inc. | Conditions: Low Back Pain | Phase 4 | Status: COMPLETED